Natural Beauty Bio-Technology Limited
Natural Beauty Bio-Technology Limited (0157.HK) Financial Performance & Income Statement Overview
Explore the financials of Natural Beauty Bio-Technology Limited (0157.HK), including yearly and quarterly data on income, cash flow, and balance sheets.
Natural Beauty Bio-Technology Limited (0157.HK) Income Statement & Financial Overview
Analyze Natural Beauty Bio-Technology Limited’s 0157.HK earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|
| Revenue | $156.75M | $174.50M | $161.51M | $172.29M |
| Cost of Revenue | $63.42M | $78.92M | $78.34M | $82.19M |
| Gross Profit | $93.33M | $95.58M | $83.17M | $90.10M |
| Gross Profit Ratio | $0.60 | $0.55 | $0.51 | $0.52 |
| R&D Expenses | $2.42M | $3.45M | $0.00 | $4.43M |
| SG&A Expenses | $121.34M | $94.58M | $87.92M | $91.49M |
| Operating Expenses | $117.91M | $94.58M | $87.92M | $91.49M |
| Total Costs & Expenses | $181.33M | $173.50M | $166.26M | $173.69M |
| Interest Income | $0.00 | $0.00 | $3.06M | $2.60M |
| Interest Expense | $4.09M | $4.17M | $3.96M | $3.00M |
| Depreciation & Amortization | $13.39M | $12.27M | $14.38M | $17.17M |
| EBITDA | -$11.19M | $12.89M | $12.03M | $21.89M |
| EBITDA Ratio | -$0.07 | $0.08 | $0.06 | $0.09 |
| Operating Income | -$24.58M | $1.00M | -$4.75M | -$1.40M |
| Operating Income Ratio | -$0.16 | $0.006 | -$0.03 | -$0.008 |
| Other Income/Expenses (Net) | -$4.09M | -$4.17M | -$1.56M | -$3.00M |
| Income Before Tax | -$28.67M | -$5.56M | -$6.31M | $1.73M |
| Income Before Tax Ratio | -$0.18 | -$0.03 | -$0.04 | $0.01 |
| Income Tax Expense | $1.78M | $146000.00 | $3.10M | $1.96M |
| Net Income | -$30.45M | -$5.71M | -$9.41M | -$223000.00 |
| Net Income Ratio | -$0.19 | -$0.03 | -$0.06 | -$0.001 |
| EPS | -$0.02 | -$0.003 | -$0.005 | -$0.00 |
| Diluted EPS | -$0.02 | -$0.003 | -$0.005 | -$0.00 |
| Weighted Avg Shares Outstanding | $2.002B | $2.002B | $2.002B | $2.002B |
| Weighted Avg Shares Outstanding (Diluted) | $2.002B | $2.002B | $2.002B | $2.002B |
Over the last four quarters, Natural Beauty Bio-Technology Limited's revenue moved from $172.29M in Q4 2022 to $156.75M in Q2 2024. Operating income in Q2 2024 was -$24.58M, with a strong operating margin of -16%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Natural Beauty Bio-Technology Limited remained robust at -$11.19M, reflecting operational efficiency. Net income dropped to -$30.45M, with an EPS of -$0.02. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan